Pathogen inactivation of double‐dose buffy‐coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function

Publisher： John Wiley & Sons Inc

E-ISSN： 1423-0410|108|4|340-349

ISSN： 0042-9007

Source： VOX SANGUINIS, Vol.108, Iss.4, 2015-05, pp. : 340-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Storage Characteristics of Split Double-Dose Platelet Concentrates Derived from Apheresis and Treated with Amotosalen Hydrochloride and UVA Light for Pathogen Inactivation

By  

Transfusion Medicine and Hemotherapy, Vol. 29, Iss. 4, 2002-08 ,pp. : 193-198

Karger

Access to resources Recommend Favorite

In vitro variables of buffy coat–derived platelet concentrates with residual plasma of down to 10% are stably maintained in new‐generation platelet additive solutions

By  

TRANSFUSION, Vol. 55, Iss. 7, 2015-07 ,pp. : 1700-1709

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma‐irradiated platelets

By  

TRANSFUSION, Vol. 55, Iss. 6, 2015-06 ,pp. : 1169-1177

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative effectiveness of plasma prepared with amotosalen‐UVA pathogen inactivation and conventional plasma for support of liver transplantation

By  

TRANSFUSION, Vol. 55, Iss. 7, 2015-07 ,pp. : 1710-1720

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tolerance of platelet concentrates treated with UVC‐light only for pathogen reduction – a phase I clinical trial

By  

VOX SANGUINIS, Vol. 109, Iss. 1, 2015-07 ,pp. : 44-51

John Wiley & Sons Inc

Access to resources Recommend Favorite